Detalhe da pesquisa
1.
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Blood Cancer J
; 12(6): 95, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750691
2.
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Leukemia
; 36(6): 1585-1595, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474100
3.
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Cancer Discov
; 10(12): 1894-1911, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826232
4.
Relative Mitochondrial Priming Predicts Survival in Older AML Patients Treated Intensively.
Hemasphere
; 7(1): e819, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36570694
5.
Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia.
Leukemia
; 32(8): 1856-1860, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29535430